§ BIOTECHNOLOGY
USD · BiotechnologyCADL
CANDEL THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 8.6M | 0.0% | +33% |
| RTW INVESTMENTS, LP | 6.4M | 0.3% | n/a |
| ACORN CAPITAL ADVISORS, LLC | 3.5M | 4.9% | +36% |
| Saturn V Capital Management LP | 2.9M | 2.6% | n/a |
| Portolan Capital Management, LLC | 2.9M | 0.8% | +71% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | 0.0% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for CADL as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER36.1% · 0 holders
OTHER37.9% · 76 holders
QUALITY / COMPOUNDER15.7% · 5 holders
PASSIVE / INDEX5.9% · 7 holders
DEALER / BANK2.6% · 16 holders
TACTICAL / MACRO1.8% · 4 holders
SYSTEMATIC / QUANT0.1% · 3 holders
INCOME / DEFENSIVE0.0% · 4 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for CADL in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention CADL yet.